Aug 2025 2025 Mid-Year Update on Novel Psychoactive Substances (NPS) Trends
The goal of this clinical update is to review the prevalence of NPS detected at Aegis and trends in detection...
Clinical Update
17 Jul Evaluating Methodologies for Monitoring Designer Drug Exposure and a Comparison of Results
in
News
Our research shows that new and dangerous drugs continue to appear in the U.S. each year. In 2024 alone, 20...
09 May Nitazene Analogs – Ongoing Evaluation of an Emerging Threat
in
News
Our research shows that new and dangerous drugs continue to appear in the U.S. each year. In 2024 alone, 20...
30 Apr NPS Frontline Alert: Medetomidine
in
News
Medetomidine is a non-opioid veterinary anesthetic that acts as a synthetic agonist at alpha-2-adrenergic receptors. It belongs to the same...
10 Apr NPS Frontline Alert: Emerging Substances
in
News
To stay current with the rapidly changing landscape of new and emerging drugs, Aegis has committed to bi-annual NPS test...
Apr 2025 Prevalent Adulterants Found in the Illicit Drug Supply
Adulterants are unreported substances added to a product, often to reduce production costs, enhance the products effects, and may increase...
